| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 2 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 293.3K | $283.5K | - | |
| CFO | 106.2K | $102.7K | - | |
| VP | 47.0K | $45.5K | - | |
| Dir | 15.7K | $15.2K | - | |
| Dir | 15.6K | $15.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | Altman Peter47 | President And CEO | Buy | 100 | $1.87 | $187.00 | - | +15.0% | +23.5% | |
| Nov 18, 2021 | Altman Peter47 | President And CEO | Buy | 5,000 | $2.20 | $11,000.00 | +2.1% | +0.5% | -14.0% | |
| Aug 17, 2021 | Altman Peter47 | President And CEO | Buy | 3,500 | $2.94 | $10,290.00 | +1.5% | -16.1% | -41.3% | |
| Dec 1, 2020 | Altman Peter47 | President And CEO | Buy | 4,200 | $2.40 | $10,067.86 | +1.0% | - | - | |
| Nov 27, 2020 | Altman Peter47 | President And CEO | Sell | 3,200 | $2.31 | $7,379.84 | -1.6% | - | - | |
| Nov 13, 2020 | Altman Peter47 | President And CEO | Buy | 2,500 | $2.07 | $5,176.00 | +0.6% | - | - | |
| Nov 10, 2020 | Altman Peter47 | President And CEO | Buy | 2,500 | $1.98 | $4,950.00 | +1.2% | - | - | |
| Nov 2, 2020 | Duckers Eric | Chief Medical Officer | Sell | 8,435 | $2.01 | $16,954.35 | -41.1% | - | - | |
| Jun 19, 2020 | Stertzer Simon H | Director, 10% Owner | Buy | 142,850 | $2.10 | $299,985.00 | +316.5% | - | - | |
| Jun 19, 2020 | Allen Jim L. | Director | Buy | 142,850 | $2.10 | $299,985.00 | +27.2% | - | - |